Učitavanje...

Synthetic Lethal Screen Identifies NF-κB as a Target for Combination Therapy with Topotecan for patients with Neuroblastoma

BACKGROUND: Despite aggressive multimodal treatments the overall survival of patients with high-risk neuroblastoma remains poor. The aim of this study was to identify novel combination chemotherapy to improve survival rate in patients with high-risk neuroblastoma. METHODS: We took a synthetic lethal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tsang, Patricia S, Cheuk, Adam T, Chen, Qing-Rong, Song, Young K, Badgett, Thomas C, Wei, Jun S, Khan, Javed
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3364855/
https://ncbi.nlm.nih.gov/pubmed/22436457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-101
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!